1. Market Research
  2. > Cytheris SA - Product Pipeline Review - 2013

Cytheris SA - Product Pipeline Review - 2013

  • June 2013
  • -
  • Global Markets Direct
  • -
  • 25 pages

Cytheris SA - Product Pipeline Review - 2013


Summary


Global Market Direct’s pharmaceuticals report, “Cytheris SA - Product Pipeline Review - 2013” provides data on the Cytheris SA’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Cytheris SA’s corporate website, SEC filings, investor presentations and featured press releases, both from Cytheris SA and industry-specific third party sources, put together by Global Markets Direct’s team.


Scope


- Cytheris SA - Brief Cytheris SA overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Cytheris SA human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Cytheris SA with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Cytheris SA’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.


Reasons to buy


- Evaluate Cytheris SA’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Cytheris SA in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Cytheris SA’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Cytheris SA.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Cytheris SA and identify potential opportunities in those areas.

Table Of Contents

Cytheris SA - Product Pipeline Review - 2013
Table of Contents 2
List of Tables 3
List of Figures 3
Cytheris SA Snapshot 4
Cytheris SA Overview 4
Key Information 4
Key Facts 4
Cytheris SA - Research and Development Overview 5
Key Therapeutic Areas 5
Cytheris SA - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Cytheris SA - Pipeline Products Glance 9
Cytheris SA Clinical Stage Pipeline Products 9
Phase II Products/Combination Treatment Modalities 9
Phase I Products/Combination Treatment Modalities 10
Cytheris SA - Early Stage Pipeline Products 11
Pre-Clinical Products/Combination Treatment Modalities 11
Cytheris SA - Drug Profiles 12
CYT-107 12
Product Description 12
Mechanism of Action 12
RandD Progress 12
CYT-209 15
Product Description 15
Mechanism of Action 15
RandD Progress 15
CYT-99 007 16
Product Description 16
Mechanism of Action 16
RandD Progress 16
Cytheris SA - Pipeline Analysis 17
Cytheris SA - Pipeline Products by Therapeutic Class 17
Cytheris SA - Pipeline Products by Route of Administration 18
Cytheris SA - Pipeline Products By Mechanism of Action 19
Cytheris SA - Recent Pipeline Updates 20
Cytheris SA - Dormant Projects 22
Cytheris SA - Locations And Subsidiaries 23
Head Office 23
Other Locations and Subsidiaries 23
Appendix 24
Methodology 24
Coverage 24
Secondary Research 24
Primary Research 24
Expert Panel Validation 24
Contact Us 25
Disclaimer 25

List of Tables


Cytheris SA, Key Information 4
Cytheris SA, Key Facts 4
Cytheris SA - Pipeline by Indication, 2013 6
Cytheris SA - Pipeline by Stage of Development, 2013 7
Cytheris SA - Monotherapy Products in Pipeline, 2013 8
Cytheris SA - Phase II, 2013 9
Cytheris SA - Phase I, 2013 10
Cytheris SA - Pre-Clinical, 2013 11
Cytheris SA - Pipeline By Therapeutic Class, 2013 17
Cytheris SA - Pipeline By Route of Administration, 2013 18
Cytheris SA - Pipeline Products By Mechanism of Action, 2013 19
Cytheris SA - Recent Pipeline Updates, 2013 20
Cytheris SA - Dormant Developmental Projects,2013 22
Cytheris SA, Subsidiaries 23

List of Figures


Cytheris SA - Pipeline by Indication, 2013 6
Cytheris SA - Pipeline by Stage of Development, 2013 7
Cytheris SA - Monotherapy Products in Pipeline, 2013 8
Cytheris SA - Pipeline By Therapeutic Class, 2013 17
Cytheris SA - Pipeline By Route of Administration, 2013 18
Cytheris SA - Pipeline Products By Mechanism of Action, 2013 19

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.